TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
1.365
+0.055 (4.16%)
Nov 5, 2024, 3:42 PM EST - Market open
TNF Pharmaceuticals Employees
TNF Pharmaceuticals had 6 employees as of December 31, 2023. The number of employees decreased by 3 or -33.33% compared to the previous year.
Employees
6
Change (1Y)
-3
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,891,924
Market Cap
3.23M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6 | -3 | -33.33% |
| Dec 31, 2022 | 9 | 0 | - |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Venus Concept | 304 |
| Regional Health Properties | 114 |
| MSP Recovery | 88 |
| Molecular Templates | 62 |
| iSpecimen | 53 |
| Scinai Immunotherapeutics | 31 |
| ReShape Lifesciences | 29 |
| GRI Bio | 4 |
TNFA News
- 4 weeks ago - TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market - Business Wire
- 2 months ago - TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline - Business Wire
- 3 months ago - TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today - Business Wire
- 3 months ago - MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc. - Business Wire
- 5 months ago - MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer - Business Wire
- 6 months ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 6 months ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 8 months ago - MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing - Business Wire